Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1092-2026

C-RAD POSITIONING AB recalls Brand Name: Catalyst+ Product Name: Catalyst

C-RAD POSITIONING ABUppsala, SwedenReported Jan 21, 2026 · 5 months ago
Legal News Analyst ·

Reason for recall

Due to issues with the system's stereotactic radiosurgery (SRS) treatment cannot be guaranteed for all couch angles and system setups. n certain cases, the system may indicate the patient as correctly positioned at the isocenter, even when the isocenter is positioned outside of the indicated tolerance.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Brand Name: Catalyst+ Product Name: Catalyst, Catalyst+ Model/Catalog Number: SP001-0026, SP003-0002 Software Version: cSRS module in combination with cMotion module Product Description: GMDN: 40893 Patient positioning device, diagnostic imaging/radiotherapy, laser Component: Not applicable

Lot / code information

Lot #
Code: Note: The error is not related to any
Serial #
or
Lot #
. The error is limited to the software module cSRS in combination with cMotion module

What the firm is doing

On 10/14/2025, the firm email an Urgent Field Safety Notice to customers informing them that C-RAD has noted a potential issue affecting the cSRS mode of the Catalyst+ HD and Catalyst HD systems. All software version above c4D 5.3.2 are affected by this issue. The issue is that the stated precision of the Catalyst system for stereotactic radiosurgery (SRS) treatments cannot be guaranteed for all couch angles and system setups. In certain cases, the system may indicate the patient as correctly positioned at the isocenter, even when the isocenter is positioned outside of the indicated tolerance. This could in the worst-case result in erroneous dose delivery. This issue affects Catalyst+ HD and Catalyst HD systems, configured for cSRS and cMotion. Customers are instructed to: 1. Ensure that all the staff operating the Catalyst+ HD and Catalyst HD, and the c4D software application are informed of this information. 2. As an immediate action, affected users are advised to not use Catalyst+ HD and Catalyst HD in combination with cSRS and cMotion. C-RAD will release a new version of the software application c4D resolving the issue and/or update IFU/labelling. For questions please contact C-RAD Quality Department as regulatory@c-rad.com

DistributionShow details

The software module cSRS has been installed in 37 countries Worldwide - U.S. Nationwide distribution in the states of AK, AL, AR, CA, CT, FL, MO, NC, NM, NY, OH, OK, OR, PA, TN, TX, VA, and WA. The countries of Argentina, Australia, Austria, Belarus, Belgium, Benin, Canada, China, Colombia, Egypt, El Salvador, Finland, France, Germany, Greece, Hungary, India, Italy, Japan, Jordan, Mexico, Morocco, Netherlands, New Zealand, Norway, Portugal, Romania, Russia, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, Ukraine, and Vietnam.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls